Efficacy and safety of pumecitinib 3% gel in treating mild-to-moderate atopic dermatitis: a multicentre randomized double-blind parallel placebo-controlled phase IIb clinical trial
Zhang Li(Chongqing Academy of Chinese Materia Medica), Aie Xu(Third People's Hospital of Hangzhou), Wenli Feng, Jiang Meiying(Nanchang University), Rixin Chen(Nanchang University), Zhihong Xie(Beijing Hospital), Yunsheng Liang(Southern Medical University), Bingjiang Lin(Ningbo University Affiliated Hospital), Liming Wu(Hangzhou First People's Hospital), Xiaoping Pei(Southern Medical University), Kunpeng Bian(Nanyang Institute of Technology), Linfeng Li(Beijing Tongren Hospital), Guoqiang Zhang(Hebei Medical University), Mingyue Wang(Peking University), Lei Cao(Wuxi No.2 People's Hospital), Yanyan Feng(Shanghai Jiao Tong University), Litao Zhang(Tianjin University of Traditional Chinese Medicine), Wenlin Yang(Second Affiliated Hospital of Guangzhou Medical University), Zudong Meng(People's Hospital of Shiyan), Yingxia He(Flower Hospital), Chao Ji(Zhongshan Hospital of Xiamen University), D. Du(Five Prime Therapeutics (United States))
Cited by 0
Related Papers
Association analyses identify six new psoriasis susceptibility loci in the Chinese population
|Nature Genetics|2010|317
SIRT1 confers protection against UVB‐ and H<sub>2</sub>O<sub>2</sub>‐induced cell death <i>via</i> modulation of p53 and JNK in cultured skin keratinocytes
|Journal of Cellular and Molecular Medicine|2008|171
Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity
|Proceedings of the National Academy of Sciences|2015|168
α‐MSH activates immediate defense responses to UV‐induced oxidative stress in human melanocytes
|Pigment Cell & Melanoma Research|2009|163
The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro
|Biochemical Pharmacology|2020|160